Crossmark

Real-world prescribing patterns and early weight and blood pressure outcomes of GLP-1–based therapies: a retrospective observational study in the United Arab Emirates

Crossref DOI link: https://doi.org/10.1186/s12902-026-02273-3

Published Online: 2026-04-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Almemari, Salma

Almulla, Nour

Alsarraf, Yasmin

Badri, Ghada

Khan, Nelofar Sami
Funding

Funding for this research was provided by:

Gulf Medical University
License Information

Text and Data Mining valid from 2026-04-12

Accepted Manuscript valid from 2026-04-12
More Information

Article History

Received: 12 February 2026

Accepted: 8 April 2026

First Online: 12 April 2026

Declarations

:

: The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Gulf Medical University ( Ref. no. IRB-COM-STD-60-Jan-2025 ). As this was a retrospective study using anonymized electronic health records, the requirement for informed consent was waived.

: Consent to publish was not applicable, as this study involved retrospective analysis of anonymized electronic health records with no identifiable patient information.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below